HomeGSK, Sanofi shares soar as Zantac litigation fears abateIllustration shows GSK (GlaxoSmithKline) logo

Illustration shows GSK (GlaxoSmithKline) logo

GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration

Zantac heartburn pills are seen in this picture illustration

Most Read

Walgreens Boots signals turnaround on track as it tops estimates, shares surge

January 10, 2025

Pfizer must face lawsuit over diversity fellowship program, US court rules

January 10, 2025

Greenland’s leader ready to talk to Trump

January 10, 2025

Exclusive-Western powers warn Syria over foreign jihadists in army, sources say

January 10, 2025